Key Takeaways From Danaher Analyst Ratings

During the last three months, 8 analysts shared their evaluations of Danaher DHR, revealing diverse outlooks from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $273.88, along with a high estimate of $290.00 and a low estimate of $260.00. Witnessing a positive shift, the current average has risen by 4.69% from the previous average price target of $261.62.

Understanding Analyst Ratings: A Comprehensive Breakdown

The standing of Danaher among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Danaher. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Danaher compared to the broader market.
• Price Targets: Gaining insights, analysts provide estimates for the future value of Danaher's stock. This comparison reveals trends in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Danaher's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Danaher analyst ratings.

Discovering Danaher: A Closer Look

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Unraveling the Financial Story of Danaher

Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.

Revenue Challenges: Danaher's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -2.57%. This indicates a decrease in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Danaher's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.77%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Danaher's ROE excels beyond industry benchmarks, reaching 2.04%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Danaher's ROA stands out, surpassing industry averages. With an impressive ROA of 1.3%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Danaher's debt-to-equity ratio is below the industry average. With a ratio of 0.34, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Basics of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.